Register
Follow Us on TwitterPERFORMANCE RANKINGS:
Hedge Funds
Sector Specific - Health Care/Biotech — Fund Assets Greater Than $10 Million as of Month-end Nov 2008
| Hedge Fund Program | Nov 2008 ROR |
YTD | |
|---|---|---|---|
| 1 | Tryphon Capital Mgmt, LLC | -0.90% | -16.32% |
| 2 | Welch Life Sciences Fund, L.P. | -2.55% | -7.62% |
| 3 | DAFNA LifeScience Market Neutral Ltd. | -3.34% | -11.57% |
| 4 | Perceptive Life Sciences Fund, L.P. | -5.19% | -22.60% |
| 5 | DAFNA LifeScience Ltd. | -6.08% | -21.68% |
| 6 | Abernathy Group Growth Trust, L.P. | -8.57% | -22.72% |
| 7 | J.W. Partners, L.P. | -8.98% | -45.77% | 8 | % | % |
| 9 | % | % | 10 | % | % |
You can download a FREE DEMO of the Barclay Institutional Report - Hedge Funds Edition where you can find performance history, program info, total assets, manager’s trading strategy on more than 3332 traders.
THE INFORMATION INCLUDED IN THIS SITE (OR IN RELATED LINKS) RELATING TO PARTICULAR FUNDS AND FUND MANAGERS IS BASED ON INFORMATION AND DATA RECEIVED BY THE BARCLAY GROUP FROM SUCH FUNDS AND MANAGERS AND FROM OTHER SOURCES. NEITHER THE BARCLAY GROUP (BARCLAY TRADING GROUP, BARCLAY RESEARCH GROUP, GLOBAL HEDGESOURCE) NOR ANY OF ITS AFFILIATES OR THEIR RESPECTIVE OFFICERS, DIRECTORS OR EMPLOYEES (I) HAVE VERIFIED THE ADEQUACY, ACCURACY OR COMPLETENESS OF ANY SUCH INFORMATION, AND THEY MAKE NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, OF ANY KIND WHATSOEVER, REGARDING THE ADEQUACY, ACCURACY OR COMPLETENESS OF ANY SUCH INFORMATION AND (II) SHALL BE LIABLE FOR ANY LOSSES, DAMAGES, COSTS OR EXPENSES, OF ANY KIND OR DESCRIPTION, RELATING TO THE ADEQUACY, ACCURACY OR COMPLETENESS OF ANY SUCH INFORMATION.
